Clinical Trials Browser

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Hypopharyngeal Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Tobacco Use Disorder, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma

NCT00534001 2017-05-30

Bupropion in Helping Adults Stop Smoking

Phase 2 Completed

95 enrolled 8 charts

GastrointestinalGenitourinaryGynecologicHead & NeckOther hematologic neoplasmThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Hypopharyngeal Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Tobacco Use Disorder, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma

NCT00322205 2017-01-11

Bio-behavioral Lung Cancer Prevention Program

Phase 4 Completed

555 enrolled

Smoking Cessation

NCT00033592 2016-07-13

Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking

Phase 3 Completed

1,708 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT01048983 2015-03-05

Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)

Phase 1/2 Withdrawn

Thoracic

cyclopia sequence, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01219673 2015-02-10

Symptom Burden in Head and Neck Cancer

Phase 1/2 Terminated

1 enrolled 2 charts

Head & Neck

cyclopia sequence, Carcinoma, Head and Neck Neoplasms, Laryngeal Diseases

NCT00032084 2013-03-11

S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery

Phase 3 Terminated

10 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00079469 2012-03-08

Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke

Phase NA Completed

Other solid neoplasm

Cancer Survivor

NCT00236288 2007-10-31

A Feasibility Study of Smoking Cessation Program in Radiation Oncology

Phase NA Completed

36 enrolled

Neoplasms, Tobacco Use Disorder

NCT00234195 2007-04-17

Wellbutrin XL, Major Depressive Disorder and Breast Cancer

Phase 4 Completed

25 enrolled

Breast

Breast Neoplasms, Depressive Disorder, Major

Clinical Trials

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

INAVO121

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

TTOP

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

A-NEW

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer

Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects

Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients

Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies

A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy

Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Bupropion in Helping Adults Stop Smoking

Bio-behavioral Lung Cancer Prevention Program

Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking

Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)

Symptom Burden in Head and Neck Cancer

S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery

Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke

A Feasibility Study of Smoking Cessation Program in Radiation Oncology

Wellbutrin XL, Major Depressive Disorder and Breast Cancer